Car T Cell Immunotherapy Articles & Analysis
4 articles found
The focus is on enhancing the immune system's natural ability to fight the malignancy. Among the various forms of immunotherapy, CAR T-cell therapy (Chimeric Antigen Receptor T-cell therapy) has shown promise, particularly in treating acute lymphoblastic leukemia (ALL), especially in children ...
These systems include Microneedle Technology, Transdermal Patches Drug Delivery System, Nanoparticle Development Services for Drug Delivery Systems, and CAR-T/CAR-NK Cells Development for Drug Delivery Systems. Microneedle Technology Microneedle technology offers a minimally invasive approach to drug delivery by creating ...
Researchers at Massachusetts General Hospital (MGH) have found that interferon gamma receptor (IFNgR) signaling is essential for the susceptibility of CAR-T cell immunotherapy to kill malignant gliomas. The same phenomenon has been observed in other solid tumors. The findings may partially explain why liquid and solid tumors ...
Using the power of large data and advanced computational methods, researchers can identify peptides on the surface of tumor cells and can target "peptide-centric" chimeric antigen receptors (PC-CARs): a new design of T cells that stimulates the immune response to eliminate tumors. ...